Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2025-12-24 @ 7:22 PM
NCT ID:
NCT02571803
Eligibility Criteria:
Inclusion Criteria:
* coronary atheroslerotic lesions confirmed in the screening CCTA with reduction of the artery diameter less than 70% in 2 or more coronary artery segments
* no indications for coronary angiography / revascularization (no documented significant ischemia of myocardium)
* free and informed consent of the person concerned
* willingness to follow the strict directions given by the investigators
Exclusion Criteria:
* any valvular heart disease requiring cardiac surgery (or expected cardiac surgery intervention within 12 moths)
* diagnosis of dilated / hypertrophic cardiomyopathy
* diagnosis of DM t. 2
* past CABG procedure
* women in reproductive age
* known genetic factors with a possible impact on the progres of coronary atherosclerotic lesions (e. i. congenital metabolic disorders, familial hyperlipidemias)
* low quality of the CCTA data
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02571803
Study Brief:
Protocol Section:
NCT02571803